- 全部删除
您的购物车当前为空
Sofituzumab是一种靶向MUC16蛋白的人源化单克隆抗体,常用于合成ADC的Sofituzumab vedotin,可用于治疗卵巢癌和胰腺癌。

为众多的药物研发团队赋能,
让新药发现更简单!
Sofituzumab是一种靶向MUC16蛋白的人源化单克隆抗体,常用于合成ADC的Sofituzumab vedotin,可用于治疗卵巢癌和胰腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 3,480 | In stock | |
| 5 mg | ¥ 7,560 | In stock | |
| 10 mg | ¥ 9,870 | In stock | |
| 25 mg | ¥ 14,900 | In stock | |
| 50 mg | ¥ 19,800 | In stock |
Sofituzumab 相关产品
| 产品描述 | Sofituzumab is a humanised monoclonal antibody targeting the MUC16 protein, commonly used in the synthetic ADC Sofituzumab vedotin, which can be used to treat ovarian cancer and pancreatic cancer. |
| 别名 | 索非妥珠单抗, MMUC1206A, MMUC 1206A |
| CAS No. | 1615692-28-8 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容